By

Larry Corey, MD

1
Dec
2020

Vaccine Scarcity: Buckle Up for Debate

The Pfizer and Moderna vaccines are likely to secure Emergency Use Authorizations (EUAs) from the FDA by Christmas. These are amazing gifts of science. They also arrive with high expectations from a weary public, especially since the clinical trials of these mRNA vaccines indicate near-complete protection from severe disease. These first two vaccines arrive at the most tumultuous time yet...
Read More
20
Nov
2020

Why the Operation Warp Speed Vaccine Studies Aren’t Limited to Severe Disease

[Editor’s Note: a version of this article was first published on Nov. 13 on the Johns Hopkins University Coronavirus Resource Center. —LT ] The COVID-19 Operation Warp Speed (OWS) trials have taken some criticism in the medical press, and lay press, for evaluating what some consider to be “trivial” characteristics of mild COVID-19 disease. Some are arguing that it would...
Read More
18
Nov
2020

The mRNA Vaccine News is Good. But Let’s Keep Masks for Now

[Editor’s Note: a version of this article was first published on the Johns Hopkins University Coronavirus Resource Center. —LT ] Clinical trials are usually designed to answer one or two specific questions. For the pivotal COVID-19 trials evaluating messenger RNA vaccines from Pfizer and Moderna, researchers are looking at whether these vaccines prevent a person from getting sick, keep them...
Read More